HopeStage
Back to all studies
CompletedNCT02704390

Safety study of Long-term Safety and Efficacy of ORADUR®-Methylphenidate in ADHD

Researchers studied ORADUR-Methylphenidate, tracking side effects to assess long-term safety in children and adolescents with ADHD.

Medication studyAges 6–18Taiwan
The study in practice

Understand this study

What did researchers investigate?

Researchers studied ORADUR-Methylphenidate, tracking side effects to assess long-term safety in children and adolescents with ADHD.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 18 years. Other eligibility criteria applied.

Listed locations
Chiayi City, Taiwan · Taipei, Taiwan and 1 more locationSee all locations and recruitment
Activities
Medication described in the protocol
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateJanuary 2016
Recruitment status
Completed
Enrollment listed in the registry
64
Sponsor
Orient Pharma Co., Ltd.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Taiwan
Age range
From 6 Years to 18 Years
Official registry ID
NCT02704390
Official title
Show the full official title

An Extension Study to Evaluate the Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chiayi City · Taipei · Taoyuan

FAQ

Questions about this study

What did researchers investigate?

Researchers studied ORADUR-Methylphenidate, tracking side effects to assess long-term safety in children and adolescents with ADHD.

Who is behind this study?

The study sponsor is Orient Pharma Co., Ltd., a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including ORADUR®-Methylphenidate.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 18 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me